gut50 (25)in #theragenomics • 6 years ago • NoneFebuxostat (Uloric) and its problem with cardiovascular mortalityDespite drug safety problems of cardiovascular mortality with Febuxostat (Uloric), the benefits might still be seen to…gut50 (25)in #theragenomics • 6 years ago • NoneGrossesse et risques de malformations: Il n'y a pas seulement le valproatemay 01, 2019 - En France, l’Agence nationale de sécurité du médicament et des produits de santé (ANSM) viens de…gut50 (25)in #theragenomics • 6 years ago • NoneLemtrada: Deleterious unwanted effects in some multiple sclerosis patientsLemtrada: Deleterious unwanted effects in some multiple sclerosis patients Alemtuzumab (Lemtrada) is used in the…